TAB A Acronyms, Abbreviations, and Glossary
ACIP | Advisory Committee on Immunization Practices |
AFEB | Armed Forces Epidemiological Board |
AFMIC | Armed Forces Medical Intelligence Center |
AOR | area of responsibility |
ARCENT | Army Central Command |
. | |
ASD(HA) | Assistant Secretary of Defense (Health Affairs) |
AVIP | Anthrax Vaccine Immunization Program |
BW | biological warfare |
CDC | Centers for Disease Control and Prevention |
CDRFORSCOM | Commander, Forces Command |
. | |
CENTCOM | Central Command |
CINC | Commander in Chief |
CINCCENT | Commander in Chief, Central Command |
CINCFOR | Commander in Chief, Forces Command |
CW | chemical warfare |
. | |
DD | Department of Defense (form) |
DEERS | Defense Eligibility and Enrollment Reporting System |
DNBI | disease and non-battle injury |
DoD | Department of Defense |
FDA | Food and Drug Administration |
. | |
FORSCOM | Forces Command (Army) |
GAO | General Accounting Office |
HHS | Department of Health and Human Services |
HSC | Health Services Command (Army) |
ICD | International Classification of Diseases |
. | |
IND | investigational new drug |
IOM | Institute of Medicine |
J4 | Joint Staff, Logistics Directorate |
MARDIV | Marine division |
MEDCOM | Medical Command (Army) |
. | |
MEDPROS | Medical Protection System (Army) |
MEDSOM | Medical Supply, Optical, and Maintenance |
MDPH | Michigan Department of Public Health |
MITS | Military Immunization Tracking System (Air Force) |
MMWR | Morbidity and Mortality Weekly Report |
. | |
MOD | Ministry of Defence (United Kingdom) |
MPOD | Medical Plans and Operations Division (J4) |
NBC | nuclear, biological, and chemical |
NCID | National Center for Infectious Diseases |
NGB | National Guard Bureau |
. | |
PAC | Presidential Advisory Committee on Gulf War Veterans' Illnesses |
PHS | Public Health Service |
PIC | personal information carrier |
SAMS | Shipboard Automated Medical System (Navy) |
SF | standard form |
. | |
UK | United Kingdom (of Great Britain and Northern Ireland) |
USACHPPM | US Army Center for Health Promotion and Preventive Medicine |
USAMRIID | US Army Medical Research Institute of Infectious Diseases |
USAMRMC | US Army Medical Research and Materiel Command |
VA | Department of Veterans Affairs |
. | |
VAERS | Vaccine Adverse Events Reporting System |
WHO | World Health Organization |
Active immunity | Immunity produced by the persons own immune system. This type of immunity can be brought about by a natural infection or by a vaccine. It is usually long lasting. (Compare with passive immunity.) |
Adjuvant | A substance added to a vaccine preparation to increase the bodys immune response to the vaccine. |
Adverse event | Any undesirable event that occurs following vaccination. An adverse event could be a true vaccine reaction, or just a coincidental event, with further research needed to distinguish between them. |
Adverse reaction | An unintended side effect of a vaccine. (The intended effect of a vaccine is to produce immunity.) Adverse reactions may be local, systemic, or allergic. |
Allergy | A condition in which the body has an exaggerated (immune) response to a substance, like a vaccine. Also known as hypersensitivity. |
Antibiotics | Drugs (medicines) used to treat or prevent infectious diseases. |
Antigen | A foreign substance (like a bacterium or virus, or parts of them) which triggers an immune response. Vaccines also contain antigens in order to trigger an immune response that is protective against subsequent disease. |
Attenuated vaccine | A vaccine prepared from live bacteria or viruses, which have been weakened so they produce immunity but do not cause disease. Also called live attenuated vaccines. (Compare with inactivated vaccine.) |
Bacteria | Tiny one-celled organisms present throughout the environment. Some bacteria cause disease (like diphtheria, tetanus, and typhoid fever). |
Biological warfare agent | A tiny organism (or toxin produced by it) used as a weapon to cause disease. |
Biologics | A classification of products derived from living sources, such as humans, animals, bacteria and viruses. Vaccines, immune globulin, and anti-toxins are biologics. |
Booster |
An additional dose of a vaccine needed periodically to "boost" the immune system (e.g. tetanus-diphtheria vaccine every 10 years). |
Chemoprophylaxis |
The use of a drugs to prevent infectious diseases (e.g., the use of anti-malarial pills). |
Effectiveness (or Efficacy) | The ability of a vaccine to produce the desired beneficial effect, i.e., to protect against a disease. |
Endemic (disease) |
(A disease) occurring continually in a population or geographic area. |
Epidemic (disease) |
(A disease) occurring in a population or geographic area in excess of what would be normally be expected. |
Epidemiology |
The study of the frequency and distribution of disease in human populations. |
Exposure | Contact with infectious agents (bacteria or viruses) in a manner that promotes transmission and increases the likelihood of disease. |
Immune system | A complex system in the body which fights disease by recognizing bacteria and viruses as foreign and developing a defense against them (the immune response). Vaccines protect against disease by stimulating the immune system to produce this immune response. |
Immunity | Protection against or resistance to disease. Immunity may be long lasting or temporary. It generally follows natural infections and is the goal of vaccinations. (See also active and passive immunity.) |
Immunization |
The process of inducing protection against a disease, usually by administering an antigen (as in a vaccine) or antibodies (as in immune globulin). (See also vaccination, but these terms are often used interchangeably.) |
Inactivated vaccine |
A vaccine prepared from killed whole bacteria or viruses, from parts of them, or from products (like toxins) produced by them. |
Investigational vaccine |
A vaccine that has been approved by the Food and Drug Administration (FDA) for use in clinical trials on humans. However, investigational vaccines are still in the testing and evaluation phase and are not licensed for use in the general public. For more detailed information, see the FDA web site at www.fda.gov/cder. |
Natural infection (or disease) | An infection (or disease) from bacteria or viruses found in the environment, such as measles, chicken pox, etc. |
Passive immunity |
Immunity produced in an animal or person and transferred to another person, usually by injection. It is effective but usually disappears in a few weeks to months. (Immune globulin and botulinum antitoxin provide passive immunity.) |
Side effect |
An undesirable effect of a vaccine. (See also adverse reaction.) |
Systemic |
Affecting the whole body. |
Toxin |
A poisonous substance produced by a living organism (e.g., a bacterium, a plant, or an animal). Some toxins can cause diseases, such as botulism and tetanus. |
Toxoid |
A vaccine prepared from an inactivated bacterial toxin. (Botulinum toxoid vaccine and tetanus-diphtheria toxoid vaccines are examples.) |
Vaccination |
The introduction into the body of bacteria or viruses (or parts or products of them) that have previously been treated to make them harmless for the purposes of inducing the development of immunity. (See also immunization.) |
Vaccine |
A preparation of weakened or killed microorganisms (or parts or products of them) used to produce immunity to a particular disease. |
Virus |
A tiny organism that multiplies within cells and can cause disease. Measles, mumps, chickenpox, and hepatitis are diseases caused by viruses. |
| First Page | Prev Page | Next Page |